MILPHARM ApS: Financial statements 2018
CVR: 35814159
Source: annual report 2018, Danish Business Authority
01/07/2017 – 30/06/2018
MILPHARM ApS (CVR 35814159) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK -7,674 and a net result of DKK -86,074 compared with DKK -10,033 the year before. Equity in the 2018 report amounted to DKK 73,429. The solvency ratio was 26.3%.
- Gross Profit
- DKK -7,674
- Profit/Loss
- DKK -86,074
- Equity
- DKK 73,429
- Total Assets
- DKK 279,462
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | - | -8 t. | -86 t. | 73 t. | - |
| 2017 | - | -7 t. | -10 t. | 160 t. | - |
| 2016 | - | -7 t. | 39 t. | 170 t. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationAbout MILPHARM ApS
MILPHARM ApS was a Danish company of the type Anpartsselskab based in Slagelse, founded in 2014. The company has been dissolved on 24 June 2022. The company was registered under the industry Investeringsselskaber. According to the 2021 annual report, the company had an average of 0 employees. In 2021, the company reported a gross profit of DKK -1,867 and a net result of DKK 175,681 compared with DKK 274,792 the year before. Equity in the 2021 report amounted to DKK 614,869.